<bill session="113" type="h" number="2301" updated="2013-11-02T06:38:23-04:00">
  <state datetime="2013-06-06">REFERRED</state>
  <status>
    <introduced datetime="2013-06-06"/>
  </status>
  <introduced datetime="2013-06-06"/>
  <titles>
    <title type="short" as="introduced">Clinical Trial Cancer Mission 2020 Act</title>
    <title type="official" as="introduced">To amend the Public Health Service Act to enhance the clinical trial registry data bank reporting requirements and enforcement measures.</title>
  </titles>
  <sponsor id="412393"/>
  <cosponsors>
    <cosponsor id="412563" joined="2013-06-06"/>
    <cosponsor id="400378" joined="2013-06-06"/>
  </cosponsors>
  <actions>
    <action datetime="2013-06-06" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2013-06-07">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government information and archives"/>
    <term name="Health information and medical records"/>
    <term name="Health programs administration and funding"/>
    <term name="Medical research"/>
    <term name="Military medicine"/>
  </subjects>
  <amendments/>
  <summary>6/6/2013--Introduced.
Clinical Trial Cancer Mission 2020 Act - Revises clinical trial registry data bank provisions of the Public Health Service Act to: (1) include a device or drug clinical trial whether or not it results in a positive or negative outcome, and (2) subject clinical trials funded by the Department of Defense (DOD) to requirements to certify information submissions to the Director of the National Institutes of Health (NIH). Restricts funding for a grantee and makes the grantee liable to the United States for repayment of any grant amount provided, if the grantee has not submitted clinical trial information within the 30-day correction period for noncompliance.</summary>
</bill>
